Results 81 to 90 of about 11,112,016 (340)
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Establishing a comprehensive apheresis medicine program in a resource‐constrained setting presents significant structural, financial, and logistical challenges. Despite the growing clinical importance of apheresis services globally, published experience from sub‐Saharan Africa remains sparse.
Folasade Adelekan‐Popoola +4 more
wiley +1 more source
The direct costs of drug-induced skin reactions [PDF]
, 2017 Objective The aim of the study was an assessment of direct costs of patients hospitalised for for skin adverse drug reactions during 2002–2012 in the Department of Dermatology at the Military Institute of Medicine (Ministry of Defence) in Warsaw.
Monika Szkultecka – Dębek +9 more
core +2 more sources
BMJ Open, 2018 Objective To evaluate type 2 diabetes mellitus (T2DM)-related direct medical costs by complication type and complication number, and to assess the impacts of complications as well as socioeconomic factors on direct medical costs. Design A cross-sectional
Haibin Wu +8 more
semanticscholar +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo +5 more
wiley +1 more source
, 2023 Total annual direct medical costs for patients with T13, T18, T21 classified by type of costs (USD) for inpatient care.
Wanvisa Udomsinprasert (778569) +4 more
core +1 more source
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Japan has one of the highest dialysis prevalence rates worldwide and a shrinking, aging population. Whether dialysis burden has entered a sustained post‐peak phase or whether recent declines partly reflect pandemic‐related disruptions remains uncertain.
Hatice Şahin +2 more
wiley +1 more source
Direct medical costs of traumatic thoracolumbar spine fractures
Acta Orthopaedica, 2005 The costs and cost-effectiveness of treatment of thoracolumbar fractures are poorly known.We estimated the costs of hospital care and outpatient visits for patients with traumatic thoracolumbar spine fractures.Stable fractures without neurological deficits were treated nonoperatively and the costs were EUR 5,100. Unstable fractures without neurological
van der Roer, N. +4 more
openaire +6 more sources
Direct medical and non-medical costs of treatment per patient by type of provider (Rs. 2010).
, 2013 Direct medical and non-medical costs of treatment per patient by type of provider (Rs. 2010).
Filip Meheus (361893) +4 more
core +1 more source
Costs of Parkinson's Disease and Antiparkinsonian Pharmacotherapy: An Italian Cohort Study [PDF]
, 2010 Objective: Antiparkinsonian pharmacotherapy is costly and the determinants of drug costs in Parkinson's disease (PD) have been poorly investigated. The objective of this study was to investigate the costs of PD and antiparkinsonian drugs in an Italian ...
Katia Longo +21 more
core +1 more source
Percentage of total direct medical costs for patients with T13, T18, and T21.
, 2023 Percentage of total direct medical costs for patients with T13, T18, and T21.
Wanvisa Udomsinprasert (778569) +4 more
core +1 more source